AngioDynamics (ANGO) Misses Q1 EPS by 4c, Reaffirms FY18 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to AngioDynamics (ANGO) Misses Q1 EPS by 4c, Reaffirms FY18 Guidance

AngioDynamics Reports Fiscal 2018 First Quarter Results

September 28, 2017 6:00 AM EDT

Q1 net sales of $85.4 million, down 3% year-over-year             Q1 GAAP earnings per share of $0.00; adjusted EPS of $0.12Q1 operating cash generation of $3.0 million; free cash flow generation of $2.5 millionCompany reaffirms fiscal 2018 guidance

ALBANY, N.Y., Sept. 28, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported first quarter financial results for the 2018 fiscal year ended August 31, 2017.

The first quarter of fiscal 2018 reflects early results of our commitment to improving our core operational efficiency and... More